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Budapest, HungaryA B S T R A C TObjective: The aim of this study was to derive a function that can
map the Nottingham Health Proﬁle (NHP) questionnaire onto a
utility measure, the EuroQol ﬁve-dimensional (EQ-5D) question-
naire index, for diabetic patients. Methods: A cross-sectional study
was performed on diabetic patients in Hungary with different
complications in which quality of life was measured by using both
the NHP questionnaire and the EQ-5D questionnaire. Ordinary
stepwise-backward least-squares regression was used to develop
a mapping function. Adjusted R2, Akaike’s information criterion,
and root mean square error were used to assess the performance of
the model. The robustness of the models was tested using 10-fold
cross-validation and bootstrapping. Results: The best-ﬁtting mod-
els were those that contained all the NHP statements as predictors
and a stepwise reduced version that contained only 19 statements.
The latter model, however, showed considerable variability in the
selection of predictors. The adjusted R2 of the former model wasee front matter Copyright & 2014, International S
r Inc.
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oránd University, Pázmány Péter sétány 1/a, 11170.68, the root mean square error was 174, and the Akaike’s
information criterion was 559.9. Conclusions: The expected value
of the EQ-5D questionnaire can be reasonably predicted on the basis
of results of the NHP in patients with diabetes mellitus. The
mapping function of the NHP onto the EQ-5D questionnaire is
capable of estimating the expected EQ-5D questionnaire utility
values in a group of patients with diabetes. The function’s applic-
ability for individual-level predictions, however, is limited. Further
research is needed to ﬁnd out whether mapping functions devel-
oped in Central-Eastern European countries are transferable to
Western European countries.
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The burden of diabetes mellitus, which is already large in most
countries, is steadily increasing with the epidemic of obesity,
inactivity, population aging, and greater longevity in patients
with diabetes [1]. An important aspect of this burden is the loss of
quality of life (QOL) among patients who suffer from complica-
tions of diabetes. Therefore, many studies regularly measure the
QOL of diabetic patients as an important outcome [2,3]. In these
studies, QOL is usually measured by using a generic or a disease-
speciﬁc instrument that does not provide utility measures. To
support an efﬁcient allocation of resources to both prevent and
control diabetes, the cost-effectiveness of alternative strategies
needs to be considered. Cost-effectiveness analysis requires,
however, preference-based utility measures of QOL. Therefore,
it would be desirable to have mapping functions that couldtranslate the results obtained by non–preference-based instru-
ments to utility values. Accordingly, the aim of this study was to
develop a function that can map the Nottingham Health Proﬁle
(NHP) questionnaire onto the EuroQol ﬁve-dimensional (EQ-5D)
questionnaire utility index.Methods
Participants, Setting
The study was performed in 15 centers in Hungary specializing in
the care of diabetic patients. Study groups were deﬁned by the
type of diabetes (type 1 or type 2), type of treatment (oral
antidiabetic or insulin treatments), and the presence of compli-
cations (visual impairment, nephropathy, neuropathy, coronaryociety for Pharmacoeconomics and Outcomes Research (ISPOR).
rtis Hungary and Sandoz Hungary.
, Department of Health Policy and Health Economics, Institute of
Budapest, Hungary.
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to the centers according to these modalities, and the centers
enrolled the patients consecutively. The primary objective of the
study was to estimate the QOL among diabetic patients with
different complications [4]. This report presents the results related
to the secondary objective, which was mapping the NHP ques-
tionnaire onto the EQ-5D questionnaire. The study was approved
by the institutional ethical boards and by the National Ethical
Board for Medical Research (8-239/2009-1018EKU). All persons gave
their informed consent before their inclusion in the study.
Instruments
All patients were asked to ﬁll in the NHP questionnaire and the EQ-
5D questionnaire [5,6]. The questionnaires were self-administered,
although help was provided by the study personnel on request. The
EQ-5D questionnaire consists of the EQ-5D descriptive system and
the EQ visual analog scale. We used the former for this study. The
EQ-5D descriptive system comprises ﬁve dimensions: mobility, self-
care, usual activities, pain/discomfort, and anxiety/depression. Each
dimension has three levels: no problems, some problems, extreme
problems. The respondent indicates which statement in each of the
ﬁve dimensions describes his state most appropriately. A total of 243
possible health states can be deﬁned this way. Utility values (EQ-5D
questionnaire index values) were attached to these states in our
analysis by using the time trade-off valuation technique from a UK
study [7]. The EQ-5D questionnaire has been validated in Hungary [8].
The 38 statements of the NHP fall into six sections: energy
(nine items), pain (eight items), emotional reactions (three items),
sleep disturbances (ﬁve items), social isolation (ﬁve items), and
physical mobility (eight items). The respondents need to consider
whether each statement applies to him or her in general. For
each section, a score is calculated according to the NHP scoring
guidelines [9]. Individual items are scored 1 for a “yes” response
and 0 for a “no” response. The score for each section represents
the summation of the item scores expressed as a percentage. As
such, the scores range from 0 to 100, with a higher number
representing greater distress. A patient-completed index of dis-
tress from the Nottingham Health Proﬁle (NHP-D) can be calcu-
lated as the sum of 24 items out of the total 38 statements [10].
The NHP was one of the ﬁrst QOL instruments validated in
Hungary [11]. As in the Hungarian validation study NHP-D
showed great reliability and sensitivity, it proved to be a valuable
outcome measure for trials for which carefully developed
disease-speciﬁc QOL measures are unavailable.
Analysis
OLS regression models
The most common method for establishing a functional relation-
ship between two QOL measures is ordinary least squares (OLS)
regression [12–17]. There are many possible ways to obtain EQ-5D
questionnaire indices from a non–preference-based instrument
such as the NHP. Having a data set in which patients have
responded to both instruments, empirical matching is the most
straightforward method. The essence of this approach is to
explore the relationship between the two instruments by using
regression analyses. Because the range of the EQ-5D questionnaire
is bounded, the use of OLS regression models risks predicted
values outside the range [12]. Alternatives would be to use
generalized linear models, tobit regression, or censored least
absolute deviations to allow for censoring. A recent review,
however, showed that the standard method for mapping to the
EQ-5D questionnaire was OLS regression [17]. The review of 90
studies found that 80% of the studies used OLS regression. There
are arguments supporting OLS. Tsuchiya et al. [15] showed that in
mapping problems such as ours, performance of the generalizedlinear model was comparable to that of the OLS regression, but not
better. They concluded that “the associated beneﬁts of generalized
linear model do not seem to outweigh its costs.” In another recent
study, where OLS, tobit, and censored least absolute deviation
models were compared, OLS turned out to be the best-performing
model because it produced the lowest RMSE and mean absolute
error and the highest R2 [18]. Taking into account the above
considerations and the fact that the range of the predicted EQ-5D
questionnaire values of our OLS models hardly exceeded the limits
(see Table 4), we decided not to use the generalized linear model.
In our analysis, the dependent variable was the overall EQ-5D
questionnaire index, while the explanatory variables were the 38
NHP items used in the different aggregation levels. The study did
not attempt to predict separately the individual EQ-5D question-
naire dimensions because previous studies showed it to be no
more efﬁcient in terms of prediction [12,14,19].
First, we regressed the overall EQ-5D questionnaire index on
the total NHP-D score as a start-up. Next, we reﬁned this basic
model by ﬁrst using the six NHP scores and later using all 38
separate statements as dependent variables.
In each model, we looked for nonlinear dependence between
the independent and the explanatory variables as a signal to put
either squared or otherwise transformed terms into the model. In
addition, we studied whether two-way interactions could lead to
better-ﬁtting statistics, which are commensurate with the higher
complexity of a given model.
If the full models ﬁtted reasonably well, then we looked for
more parsimonious models by running stepwise backward
regression. We started with the full model and set the removal
criterion to P ¼ 0.1 and the reentry criterion to P ¼ 0.05. This
means that if a predictor was not signiﬁcant at the level of 0.1, it
was removed from the model but it could reenter if its signiﬁ-
cance reached 0.05 after removing other predictors.
OLS regression assumptions were examined by using the
following methods:1. The variance inﬂation factor (VIF) index was used to test
collinearity. Some of the problematic (VIF index 410) predic-
tors were removed.2. Nonlinearity in any of the predictors was checked with the
help of augmented partial residual plots.3. Normality assumption for regression residuals was checked
by plotting the quantiles of the regression residuals against
the quantiles of standard normal distribution (Q-Q plot).4. The assumption of the homoscedasticity of the residuals was
visually checked by plotting predicted values against standar-
dized residuals because known statistical tests for homoscedas-
ticity are very sensitive to the violation of the normality assump-
tion and cannot be used if the normality assumption fails.Assessment of goodness of ﬁt
Goodness of ﬁt and predictive power were measured with the
root mean square error (RMSE), the adjusted R2 indices, and
Akaike’s information criterion (AIC). AIC is an information-
theoretical model selection criteria with the advantage of applic-
ability to non-nested models. Lower AIC values indicate a better
model. The range of the predicted EQ-5D questionnaire values is
also reported because OLS models struggle to produce EQ-5D
questionnaire indices that are negative or equal to 1.
Internal validity
Judging the internal validity of the results is of primary importance
when predictive models are built. Because no external data set is
available, within-sample validation was carried out with the help of
replication techniques. Two tests were conducted. First, stability of
model coefﬁcients is of interest because the relatively large number
of predictors may lead to an overparametrized model. Stability,
Table 2 – Summary statistics of the NHP and EQ-5D
questionnaire domain scores.
Dimension N Mean  SD Median
NHP1 (Energy) 936 38.82  35.50 33.33
NHP2 (Pain) 931 27.40  29.17 12.50
NHP3 (Emotional
reactions)
925 20.00  24.39 11.11
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Second, stepwise backward selections were validated by reﬁtting
the stepwise-backward model in 200 independent bootstrap sam-
ples of the same size as the original model had, using simple
random sampling with replacement. The validity, robustness of the
selection, is described in terms of what percentage of the replica-
tions retrieve each of the predictors selected in the original model.
The whole analysis was conducted by using the software
package STATA 10.0 (StataCorp, College Station, TX) [20].NHP4 (Sleep disturbance) 938 28.40  30.21 20.00
NHP5 (Social isolation) 929 8.29  18.66 0.00
NHP6 (Mobility) 926 32.17  28.99 25.00
EQ-5D1 (Mobility) 940 1.62  0.53 2.00
EQ-5D2 (Self-care) 936 1.24  0.47 1.00
EQ-5D3 (Usual activity) 941 1.55  0.68 1.00
EQ-5D4 (Pain/discomfort) 940 1.68  0.58 2.00
EQ-5D5 (Anxiety/
depression)
940 1.52  0.60 1.00
NHP-D 918 5.06  4.96 4.00
Overall EQ-5D
questionnaire index
934 0.66  0.31 0.73
EQ-5D, EuroQol ﬁve-dimensional; NHP, Nottingham Health Proﬁle.Results
A total of 943 diabetic patients participated in the study. Table 1
shows the main characteristics of the study population. Most of
them suffered from type 2 diabetes. All major complications of
diabetes mellitus were represented in the study population.
Missing Data
The rate of missing scores varied between 0.5% and 1.9%. The
NHP-D index could not be calculated in 2.7% of the participants.
The ﬁve dimensions of the EQ-5D questionnaire had a missing
rate between 0.2% and 0.7%, resulting in a 1% missing rate
regarding the overall score.
Table 2 presents the summary statistics of the scores in
question. As Fig. 1 shows, the distribution of the EQ-5D question-
naire index was heavily skewed, with 21% of the indices equal to 1,
80% of the indices greater than 0.5 and only 5% below 0.
NHP-D score regression
This model was ﬁtted on the data of 912 participants with data on
the NHP-D score and the EQ-5D questionnaire index. In these
participants, the NHP-D had a range of 0 to 24 and the EQ-5D
questionnaire index had a range of0.594 to 1. The predictive powerTable 1 – Characteristics of the study population.
Characteristic (N ¼ 943) % or mean  SD
Sex: Male 54.4
Age (y) 61.0  13.1
Type 2 diabetes 84.5
Time since diagnosis of diabetes (y) 14.3  10.5
Visual impairment
0.1 o¼ visual acuity o 1 15.6
Visual acuity o 0.1 5.5
Nephropathy
Only laboratory ﬁnding 11.2
Symptomatic 6.8
Neuropathy*
Sensomotoric symptoms 19.2
Ulcer or minor amputation 8.5
Autonomic neuropathy 7.4
Coronary heart disease
Without acute event 11.5
With acute event 10.0
Cerebrovascular disease
TIA 9.7
Stroke 5.8
Peripheral artery disease*
Symptoms 7.7
Amputation 8.4
TIA, transient ischemic attack.
* A patient could belong to multiple categories.of the total NHP-D score was relatively poor, with an adjusted R2 of
0.487, AIC of 176.09, and RMSE of 0.219. For the latter, we used the
Huber-White variance estimation because the residuals increased
toward the higher end of the NHP-D, indicating that prediction
errors were affected by poorer health. In addition, the normality
assumption for the residuals did not meet perfectly, though it might
have had only a marginal effect on the conﬁdence intervals.
NHP Scores Regression
Next, we regressed the EQ-5D questionnaire index on the six NHP
scores using 900 observations without missing values. The VIF did
not indicate a high collinearity for any of the six predictors out of
which four proved to be signiﬁcant (energy, pain, emotional
reactions, and mobility). According to the Q-Q plot, residuals were
not far from being normally distributed, although a rather hetero-
scedastic and, thus, robust variance estimation was used in this
case. There was a large progress, as the adjusted R2 changed to
0.645, and as the AIC changed to 497.024. With RMSE being 0.183,
however, there was an 11% average error in terms of the whole
range of the EQ-5D questionnaire scale (0.594 to 1). Augmented
partial residual plots did not indicate that any nonlinear terms
would have been beneﬁcial as additions to the model. The stepwise
backward selection retrieved only the four signiﬁcant predictors.
The goodness-of-ﬁt statistics were nearly unchanged, with adjusted
R2 ¼ 0.645, AIC ¼ 503.414, and RMSE ¼ 0.183. Two-way inter-
actions could not be taken into account because of multicollinearity
problems indicated by the VIF analysis.
NHP Statements Regression
The 38 individual NHP statements were entered into the model as
dummy explanatory variables. Because of the heteroscedastic
pattern of the residuals, a Huber-White variance estimator was
used for the model calculations. The model performance showed
only a marginal improvement compared with the previous model,
with an adjusted R2 of 0.680, AIC of 559.835, and RMSE of 0.174.
The signiﬁcant coefﬁcients were all negative with the exception of
statement EM4, “the days seem to drag,” and statement SO3, “I feel
there is nobody I am close to,” which are counterintuitive in their
sign (Table 3). Fig. 2 presents the ﬁtted versus observed values plot.
The stepwise backward selection removed 19 of the 38 NHP
statements; EM4 and SO3 both remained in the model with
0
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Fig. 1 – Histogram of the EQ-5D questionnaire index
(N ¼ 934). EQ-5D, EuroQol ﬁve-dimensional.
Table 3 – Coefﬁcients with robust standard errors of the
Full model (N ¼ 900)Statement
Coefﬁcient P 4 |t| 95% CI
EM1 0.0937 o103 0.1385 to 0.0
EM2 0.0080 0.8 0.0424 to 0.058
EM3 0.0420 0.01 0.0750 to 0.0
EM4 0.0504 0.01 0.0105 to 0.090
EM5 0.0136 0.3 0.0404 to 0.013
EM6 0.0095 0.6 0.0503 to 0.031
EM7 0.0348 0.2 0.0861 to 0.016
EM8 0.1075 0.005 0.1821 to 0.0
EM9 0.0084 0.7 0.0547 to 0.037
EN1 0.0080 0.6 0.0243 to 0.040
EN2 0.0532 0.03 0.1009 to 0.0
EN3 0.0290 0.05 0.0580 to 0.0
P1 0.0352 0.03 0.0674 to 0.0
P2 0.1518 o103 0.2245 to 0.0
P3 0.0304 0.3 0.0277 to 0.088
P4 0.0243 0.2 0.0625 to 0.014
P5 0.0280 0.1 0.0075 to 0.063
P6 0.0600 0.01 0.1057 to 0.0
P7 0.0219 0.3 0.0649 to 0.021
P8 0.0148 0.5 0.0608 to 0.031
PM1 0.0185 0.4 0.0654 to 0.028
PM2 0.0507 0.001 0.0798 to 0.0
PM3 0.0913 0.03 0.1746 to 0.0
PM4 0.0354 0.06 0.0719 to 0.001
PM5 0.0451 0.04 0.0875 to 0.0
PM6 0.0782 0.001 0.1255 to 0.0
PM7 0.0573 o103 0.0883 to 0.0
PM8 0.1389 o103 0.1856 to 0.0
SL1 0.0041 0.8 0.0421 to 0.033
SL2 0.0056 0.7 0.0319 to 0.020
SL3 0.0149 0.5 0.0602 to 0.030
SL4 0.0183 0.3 0.0506 to 0.014
SL5 0.0064 0.7 0.0316 to 0.044
SO1 0.0313 0.2 0.0803 to 0.017
SO2 0.0406 0.2 0.0230 to 0.104
SO3 0.0718 0.04 0.0051 to 0.138
SO4 0.0725 0.04 0.1404 to 0.0
SO5 0.0127 0.8 0.1121 to 0.086
Constant 0.9326 o103 0.9161 to 0.949
CI, conﬁdence interval; EM, emotional reactions; EN, energy; P, pain; SL,
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correct signs. The predictive power of the model was similar to
that of the full model; the adjusted R2 was 0.676, AIC was
564.655, and RMSE was 0.175. This model could have been
augmented with two-way interactions, although severe multi-
collinearity problems were apparent among the interaction terms
and were, therefore, not explored further.Summary of Model Results
Table 4 summarizes the settings and goodness-of-ﬁt statistics of
the above models. In terms of AIC, the model with NHP state-
ments as predictors performed the best. The predicted EQ-5D
questionnaire range of the full model was slightly wider than that
of the stepwise reduced model: 0.23 to 1.05 versus 0.19 to 0.99.
It was still considerably narrower, however, than the range of the
observed data, which was 0.594 to 1. The two models that
regressed the EQ-5D questionnaire index on the NHP scores were
worse than the models with NHP statements as predictors inmodels with NHP statements as predictors.
Stepwise selection (N ¼ 909)
Coefﬁcient P 4 |t| 95% CI
489 0.0999 o103 0.1436 to 0.0562
3 – – –
091 0.0455 0.003 0.0752 to 0.0158
2 0.0497 0.01 0.0116 to 0.0877
2 – – –
4 – – –
5 0.0467 0.05 0.0942 to 0.0008
330 0.1189 0.001 0.1912 to 0.0465
9 – – –
4 – – –
056 0.0598 0.01 0.1067 to 0.0128
001 0.0292 0.04 0.0566 to 0.0017
029 0.0386 0.01 0.0690 to 0.0082
791 0.1407 o103 0.2090 to 0.0723
6 – – –
0 – – –
5 – – –
142 0.0639 0.004 0.1067 to 0.0210
1 – – –
2 – – –
4 – – –
217 0.0475 0.002 0.0774 to 0.0176
079 0.0893 0.03 0.1713 to 0.0073
1 0.0512 o103 0.0797 to 0.0227
028 0.0467 0.03 0.0891 to 0.0042
308 0.0829 0.001 0.1298 to 0.0360
263 0.0543 o103 0.0831 to 0.0255
922 0.1479 o103 0.1922 to 0.1037
9 – – –
7 – – –
5 – – –
1 – – –
5 – – –
6 – – –
2 – – –
5 0.0651 0.03 0.0049 to 0.1253
047 0.0664 0.05 0.1339 to 0.0012
7 – – –
2 0.9228 o103 0.9059 to 0.9396
sleep disturbance; SO, social isolation; M, physical mobility.
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Fig. 2 – Fitted versus observed values from the full model
with NHP statements as predictors (N ¼ 900). EQ-5D, EuroQol
ﬁve-dimensional; NHP, Nottingham Health Proﬁle.
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tions for the EQ-5D questionnaire index.
When choosing between models, one must also consider
internal validity tests. To test the stability of the stepwise
selection, we bootstrapped the selection procedure 200 times to
see how much variability was seen in the list of the selected
variables. The 19 most frequently selected variables were exactly
the same predictors as in the original stepwise reduced model
with NHP statements as predictors. Twelve of the 19 predictors
were retrieved less than 90% of the time, while 3 were retrieved
less than 70% of the time. The results seem to indicate some
variability in the selection.
We tested the full model against overﬁtting. Its RMSE was 0.174.
We used 10-fold cross-validation to determine whether we would
obtain a similar ﬁgure ﬁtting the model on nine-tenth of the sample
population and applied the coefﬁcients on the remaining one-tenth
of the data. The average increase in RMSE between the training set
predictions and validation set predictions was small in size (0.007),
while the variation across the 10 trials was 0.032.
Taking all the results into account, we prefer the full model
because it ﬁtted only marginally worse than the reduced one but
was considerably better than the other three models. However,
internal validation showed the full model to be more robust than
the reduced one.Discussion
Usually, mapping functions of generic or disease-speciﬁc QOL
instruments to predict utility measures are developed in WesternTable 4 – Description of the models ﬁtted with the result
Predictor Selection N Adjusted R2 R
NHP-D score Enter 912 0.487 0
NHP scores Enter 900 0.645 0
NHP scores Stepwise 905 0.645 0
NHP statements Enter 900 0.680 0
NHP statements Stepwise 909 0.676 0
AIC, Akaike’s information criterion; EQ-5D, EuroQol ﬁve-dimensional; N
Nottingham Health Proﬁle; RMSE, root mean square error.Europe or North America. There is limited evidence on the trans-
ferability of these mapping functions to emerging markets, such as
Central-Eastern European countries. Our study is among the ﬁrst to
derive a mapping function of a generic QOL instrument in Central-
Eastern Europe. Further research is needed to ﬁnd out whether
mapping functions developed in Central-Eastern European coun-
tries are transferable to Western European countries.
We found that the expected value of a preference-based QOL
measure (EQ-5D questionnaire index) can be reasonably pre-
dicted on the basis of results of a generic QOL instrument (NHP)
in patients with diabetes mellitus. NHP is a widely used instru-
ment with proper validation to Hungary. With the mapping
function developed in this study, it is possible to translate the
results of both existing and future studies in which NHP is used
in diabetic patients to the utility scale of the EQ-5D questionnaire
and, also, to use these estimates in economic analyses.
Responsiveness of the EQ-5D questionnaire and the NHP has
already been studied in elderly patients with femoral neck frac-
tures. The authors found that both the EQ-5D questionnaire and the
NHP were responsive. The ﬁndings indicated an advantage for the
EQ-5D questionnaire. The empirical overlap between change scores
from the two instruments was limited [21]. To our knowledge, this
mapping of the NHP questionnaire onto the EQ-5D questionnaire
utility scale described in this article is the ﬁrst attempt to establish a
direct connection between the two instruments.
Brazier et al. [12] carried out a systematic review of the
literature that developed any mapping techniques between
non–preference-based and preference-based instruments. Some
technical problems that were found in previous studies occurred
in our study, as well. The range of the predicted utility values was
narrower than the range of the observed values. This ﬁnding is
mainly due to the lack of data from the lower end of the EQ-5D
questionnaire scale. Former studies also observed the skewness
of the distribution of the EQ-5D questionnaire values, which
affects the reliability of the conﬁdence interval of the parameter
estimates [12,14]. Nevertheless, this phenomenon does not limit
the applicability of the mapping function. We had two explan-
atory variables, namely, EM4 (“the days seem to drag”) and SO3 (“I
feel there is nobody I am close to”), with coefﬁcients exhibiting
opposite signs from those expected in the full and the reduced
models with NHP statements as predictors. Nevertheless, we did
not exclude them from the function because they were statisti-
cally signiﬁcantly related to the EQ-5D questionnaire index.
However, our function showed divergent validity, too, because
in the full model with NHP scores as predictors the two non-
signiﬁcant scores in Model 2a were “Sleep disturbance” and
“Social isolation.” These two scores were not covered by the ﬁve
dimensions of the EQ-5D questionnaire, while the other four
scores had their counterparts in the other instrument.
In all our models, the RMSE at the individual level was larger
than the published minimally important differences for the
EQ-5D questionnaire [22]. It nevertheless does not limit thes of goodness of ﬁt.
MSE AIC Predicted EQ-5D questionnaire range
.219 176.09 0.16 to 0.88
.183 497.02 0.08 to 0.96
.183 503.41 0.08 to 0.95
.174 559.84 0.23 to 1.05
.175 564.66 0.19 to 0.99
HP, Nottingham Health Proﬁle; NHP-D, index of distress from the
V A L U E I N H E A L T H R E G I O N A L I S S U E S 4 C ( 2 0 1 4 ) 3 1 – 3 636applicability of the mapping function because the purpose of
mapping functions is to estimate differences across groups of
patients or differences between treatment arms over time.
We used a UK tariff valuation of the EQ-5D questionnaire.
Although it is beneﬁcial to estimate national tariffs [23,24],
Hungarian tariff values of the EQ-5D questionnaire are unfortu-
nately unavailable. Similarly, the preferences of diabetic patients
might differ across countries, which may restrict the applicability
of the mapping function developed in our study. Another limi-
tation of our study is that the order of the administration of the
questionnaires was not randomized, and responses in one test
might have affected the responses in the other.
Although we tested the robustness of our results using
internal validation, it may be important to externally test the
validation of the proposed function in a different series of
diabetic patients before the function is actually used to estimate
utility values for economic analysis.Acknowledgments
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